Pasithea Therapeutics prices $30.4M private placement of 8.68M shares and warrants at $3.50/unit.

Pasithea Therapeutics Corp.

Gross proceeds $30.4M from sale of 8.68M shares and accompanying warrants at $3.50 per unit.
Warrants immediately exercisable at $3.50, expire in 5 yrs; cashless exercise and ownership limits apply.
EF Hutton receives 9% cash fee plus 1% non-accountable expense fee and up to $70K accountable expenses.
Proceeds to fund pre-clinical R&D, US/UK clinic businesses, and working capital; resale registration due within 15 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.